Study To Evaluate The Safety, Tolerability And Immunogenicity Of 4 mg Of ITI-3000 In Patients With Polyomavirus-Positive Merkel Cell Carcinoma (MCC)

Name: Study To Evaluate The Safety, Tolerability And Immunogenicity Of 4 mg Of ITI-3000 In Patients With Polyomavirus-Positive Merkel Cell Carcinoma (MCC)
License: Public Domain

Immunomic Therapeutics, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

merkel cell carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 174955
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.